Innate Pharma - ADR Live Stock Price Today, Share Analysis and Chart

Name: Innate Pharma - ADR: Is Infosys Ltd. worth buying?
Item: Innate Pharma - ADR
Rating: 1.10416675
Author: Trendlyne DVM scores

about

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Enga...

2.04 0.00 (0.00%)

41.88% Fall from 52W High

1,370

XNAS Volume

XNAS 09 Sep, 2025 12:02 PM (EDT)

Board Meeting

The next board meeting for Innate Pharma - ADR is on 17 Sep 2025 for the purpose of Innate Pharma SA Second Quarter Earnings Result for 2025 See details

Not Eligible

Expensive Valuation

1.7 / 100

Technically Neutral

42.5 / 100

1Yr Price target upside is 287%

4 analysts

Innate Pharma ADR Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..